Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: January 29, 2002		BIOPURE CORPORATION
	By:	/s/ FRANCIS H. MURPHY
		Francis H. Murphy
		Chief Financial Officer

     Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature				Title		Date
/s/ CARL W. RAUSCH Carl W. Rausch				Chairman and Chief Executive Officer		January 29, 2002
/s/ DAVID N. JUDELSON David N. Judelson				Director, Vice Chairman		January 29, 2002
/s/ PAUL A. LOONEY Paul A. Looney				Director, President		January 29, 2002
/s/ DANIEL P. HARRINGTON Daniel P. Harrington				Director		January 29, 2002
/s/ C. EVERETT KOOP, M.D. C. Everett Koop, M.D.				Director		January 29, 2002
/s/ CHARLES A. SANDERS, M.D. Charles A. Sanders, M.D.				Director		January 29, 2002
/s/ J. RICHARD CROUT, M.D. J. Richard Crout, M.D.				Director		January 29, 2002
/s/ FRANCIS H. MURPHY Francis H. Murphy				Chief Financial Officer		January 29, 2002